66. Patient D stated that Dr. El-Beshir was not present at his scheduled office

visits during the fall and winter of 2014.

67. Patient D stated that the Respondent would provide her with prescriptions
whenever Dr. El-Beshir was not present at her scheduled appointments. Patient D
stated that she witnessed the Respondent writing prescriptions for patients in the
waiting room with her, when Dr. El-Beshir was not present at the office.

68. Patient D witnessed the Respondent signing Dr. El-Beshir’s signature on her
paper prescriptions.

PATIENT E

69. On or about July 22, 2015, Board staff contacted Patient E by telephone
regarding the care and treatment she received at Facility A.

70. From September 2012 through at least July 2015, Patient E received

psychiatric and substance abuse treatment at Facility A. Patient E was being prescribed
Suboxone, Xanax, and Adderall.'*

71. Patient E stated that she recalled Dr. El-Beshir missed scheduled appointments
with her toward the end of 2014 because Dr. El-Beshir had become ill.

72. Patient E stated that she never witnessed the Respondent writing prescriptions
for her, but the Respondent would hand monthly prescriptions to her and other patients

in the waiting room.

"4 Adderall is a Schedule I! Controlled Dangerous Substance (“CDS”) amphetamine which treats Attention
Deficit Hyperactivity Disorder (ADHD) and narcolepsy.

13
